Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 139 Carcinoma, Intraductal, Noninfiltrating 8 Neoplasm Metastasis 6 Breast Carcinoma In Situ 5 Breast Neoplasms, Male 4 Breast Diseases 4 Arthralgia 4 Triple Negative Breast Neoplasms 3 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Advanced Breast Cancer 3 Neoplasms 2 Breast Cancer Metastatic 2 Solid Tumor 1 Sexual Dysfunctions, Psychological 1 Sexual Dysfunction, Physiological 1 Seizures 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Osteoporosis 1 Obesity 1 Muscle Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Locoregional Recurrence 1 Invasive Breast Cancer 1 Hypogonadism 1 Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × HER2 Negative Breast Cancer × Anastrozole × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡